Thus, these data suggested that S100A8/A9 activates the p38 MAPK/JNK/AP-1 pathway, which upregulates CCL2 and CCL6 and IL-1β expression, thereby leading to an early inflammatory response induced by TAC. Here, CCL2 is linked to persistent truncus arteriosus.